Skip to main content
Have a personal or library account? Click to login
Optimal scan time for evaluation of parathyroid adenoma with [18F]-fluorocholine PET/CT Cover

Optimal scan time for evaluation of parathyroid adenoma with [18F]-fluorocholine PET/CT

Open Access
|Nov 2015

References

  1. 1. Lew JI, Solorzano CC. Surgical management of primary hyperparathyroidism: state of the art.2009;1205-25.
  2. 2. Wada Y, Kunimura T, Sato S, Hisayuki T, Sato M, Imataka H, et al. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.2008;319-28.
  3. 3. Yamaguchi S, Yachiku S, Morikawa M. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.1997;2681-8.
  4. 4. Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism.2007;2075-80.
  5. 5. Dowthwaite SA, Young JE, Pasternak JD, Yoo J. Surgical management of primary hyperparathyroidism.2013;48-53.
  6. 6. Wang CA. Surgical management of primary hyperparathyroidism.1985;1-50.
  7. 7. Ruda JM, Hollenbeak CS, Stack BC, Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.2005;359-72.
  8. 8. Miccoli P, Pinchera A, Cecchini G, Conte M, Bendinelli C, Vignali E, et al. Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism.1997;429-30.
  9. 9. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism.2000;732-42.
  10. 10. Sosa JA, Udelsman R. Minimally invasive parathyroidectomy.2003;125-34.
  11. 11. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.2005;472-479.
  12. 12. Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99mTc sestamibi-a new agent for parathyroid imaging.1989;791-4.
  13. 13. Borley NR, Collins RE, O’Doherty M, Coakley A. Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration.1996;989-91.
  14. 14. Carneiro-Pla DM, Solorzano CC, Irvin GL, 3rd. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring.2006;715-22.
  15. 15. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.2007;1084-9.
  16. 16. Berri RN, Lloyd LR. Detection of parathyroid adenoma in patients with primary hyperparathyroidism: the use of office-based ultrasound in preoperative localization.2006;311-4.
  17. 17. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.2002;241-9.
  18. 18. Mapelli P, Busnardo E, Magnani P, Freschi M, Picchio M, Gianolli L, et al. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.2012;593-5.
  19. 19. Quak E, Lheureux S, Reznik Y, Bardet S, Aide N. F18-choline, a novel PET tracer for parathyroid adenoma?2013;3111-2.
  20. 20. Lezaic L, Rep S, Jensterle SM, Hocevar M, Fettich J. 18F-fluorocholine PET/CT for localization of hyper functioning parathyroid tissue in primary hyperparathyroidism: a pilot study.2014;2083-9.
  21. 21. Nakayama M, Okizaki A, Ishitoya S, Sakaguchi M, Sato J, Aburano T. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.2013;163-9.
  22. 22. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 4th edition Philadelphia: Elsevier/Saunders; 2012. p. 253-270.
  23. 23. Chien D, Jacene H. Imaging of parathyroid glands.2010;399-415.
  24. 24. Hellman P, Ahlström H, Bergström M, Sundin A, Långström B, Westerberg G, et al. Positron emission tomography with 11C-methionine in hyperparathyroidism.1994;974-81.
  25. 25. Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.2004;1405-12.
  26. 26. Oksüz MO, Dittmann H, Wicke C, Müssig K, Bares R, Pfannenberg C, et al. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT/CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.2011;297-307.
  27. 27. Giussani A, Janzen T, Uusijarvi-Lizana H, Tavola F, Zankl M, Sydoff M, et al. A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients.2012;985-93.
  28. 28. Tavola F, Janzen T, Giussani A, Facchinetti D, Veronese I, Uusijärvi-Lizana H, et al. Nonlinear compartmental model of 18F-choline.2012;261-8.
  29. 29. DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.2001;110-7.
DOI: https://doi.org/10.1515/raon-2015-0016 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 327 - 333
Submitted on: Jan 6, 2015
Accepted on: Mar 31, 2015
Published on: Nov 27, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Sebastijan Rep, Luka Lezaic, Tomaz Kocjan, Marija Pfeifer, Mojca Jensterle Sever, Urban Simoncic, Petra Tomse, Marko Hocevar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.